Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Cory Kasimov's Stock Ratings
Evercore ISI Group Analyst
Cory Kasimov is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/02/2025
Overall Average Return
17.9%
Smart Score
Overall Average Return Percentile
78th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2025 | MRNA | Buy Now | Moderna | $27.51 | 16.32% | Cory Kasimov69% | $50 → $32 | Maintains | In-Line | Get Alert |
| 04/24/2025 | NBIX | Buy Now | Neurocrine Biosciences | $109.99 | 68.2% | Cory Kasimov69% | $190 → $185 | Maintains | Outperform | Get Alert |
| 03/12/2025 | SMMT | Buy Now | Summit Therapeutics | $28.74 | 4.38% | Cory Kasimov69% | → $30 | Initiates | → Outperform | Get Alert |
| 02/12/2025 | SWTX | Buy Now | SpringWorks Therapeutics | $46.24 | 40.56% | Cory Kasimov69% | $60 → $65 | Maintains | Outperform | Get Alert |
| 01/27/2025 | MRNA | Buy Now | Moderna | $27.51 | 81.75% | Cory Kasimov69% | $60 → $50 | Maintains | In-Line | Get Alert |
| 12/23/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.12 | 27.81% | Cory Kasimov69% | $45 → $50 | Maintains | Outperform | Get Alert |
| 12/17/2024 | EWTX | Buy Now | Edgewise Therapeutics | $17.27 | 189.52% | Cory Kasimov69% | $45 → $50 | Maintains | Outperform | Get Alert |
| 11/22/2024 | EWTX | Buy Now | Edgewise Therapeutics | $17.27 | 160.57% | Cory Kasimov69% | → $45 | Initiates | → Outperform | Get Alert |
| 11/20/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $46.24 | 29.74% | Cory Kasimov69% | → $60 | Initiates | → Outperform | Get Alert |
| 11/19/2024 | BNTX | Buy Now | BioNTech | $105.42 | 18.57% | Cory Kasimov69% | $110 → $125 | Upgrade | In-Line → Outperform | Get Alert |
| 10/30/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 68.89% | Cory Kasimov69% | $115 → $105 | Maintains | Outperform | Get Alert |
| 10/24/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $607.48 | 93.42% | Cory Kasimov69% | $1250 → $1175 | Maintains | Outperform | Get Alert |
| 08/07/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.12 | 15.03% | Cory Kasimov69% | $50 → $45 | Maintains | Outperform | Get Alert |
| 08/06/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 84.98% | Cory Kasimov69% | $113 → $115 | Maintains | Outperform | Get Alert |
| 06/27/2024 | MRNA | Buy Now | Moderna | $27.51 | 336.21% | Cory Kasimov69% | $120 → $120 | Maintains | In-Line | Get Alert |
| 05/14/2024 | ACLX | Buy Now | Arcellx | $66.73 | 27.37% | Cory Kasimov69% | → $85 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.12 | 27.81% | Cory Kasimov69% | → $50 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.99 | 59.11% | Cory Kasimov69% | → $175 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | MRNA | Buy Now | Moderna | $27.51 | 336.21% | Cory Kasimov69% | → $120 | Initiates | → In-Line | Get Alert |
| 05/14/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $607.48 | 89.31% | Cory Kasimov69% | → $1150 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 81.76% | Cory Kasimov69% | → $113 | Initiates | → Outperform | Get Alert |
| 05/14/2024 | BNTX | Buy Now | BioNTech | $105.42 | -5.14% | Cory Kasimov69% | → $100 | Initiates | → In-Line | Get Alert |
| 02/27/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.37 | 123.52% | Cory Kasimov69% | $84 → $88 | Maintains | Overweight | Get Alert |
| 06/05/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | Cory Kasimov69% | $260 → $250 | Maintains | Overweight | Get Alert |
| 02/11/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.37 | 235.28% | Cory Kasimov69% | → $132 | Upgrade | Neutral → Overweight | Get Alert |
| 01/05/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Cory Kasimov69% | → $50 | Initiates | → Overweight | Get Alert |
| 12/21/2021 | BIIB | Buy Now | Biogen | $122.42 | 125.45% | Cory Kasimov69% | $324 → $276 | Maintains | Neutral | Get Alert |
| 09/30/2021 | KRTX | Buy Now | Karuna Therapeutics | — | — | Cory Kasimov69% | → $162 | Initiates | → Overweight | Get Alert |
| 03/01/2021 | SANA | Buy Now | Sana Biotechnology | $1.94 | 1704.03% | Cory Kasimov69% | → $35 | Initiates | → Neutral | Get Alert |
| 02/17/2021 | BLUE | Buy Now | bluebird bio | $4.00 | 875% | Cory Kasimov69% | $1520 → $780 | Downgrade | Overweight → Neutral | Get Alert |
| 02/12/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.37 | 319.1% | Cory Kasimov69% | → $165 | Downgrade | Overweight → Neutral | Get Alert |
| 07/29/2020 | AMGN | Buy Now | Amgen | $279.90 | -17.11% | Cory Kasimov69% | $225 → $232 | Maintains | Neutral | Get Alert |
| 07/20/2020 | MRNA | Buy Now | Moderna | $27.51 | 223.52% | Cory Kasimov69% | $60 → $89 | Downgrade | Overweight → Neutral | Get Alert |
| 06/18/2020 | AMGN | Buy Now | Amgen | $279.90 | -19.61% | Cory Kasimov69% | $219 → $225 | Maintains | Neutral | Get Alert |
| 05/06/2020 | INCY | Buy Now | Incyte | $62.48 | — | Cory Kasimov69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/01/2020 | GILD | Buy Now | Gilead Sciences | $103.67 | — | Cory Kasimov69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 04/17/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Cory Kasimov69% | $168 → $163 | Maintains | Overweight | Get Alert |
| 04/15/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $607.48 | -29.38% | Cory Kasimov69% | $375 → $429 | Maintains | Neutral | Get Alert |
| 03/18/2020 | BNTX | Buy Now | BioNTech | $105.42 | -68.7% | Cory Kasimov69% | → $33 | Downgrade | Overweight → Neutral | Get Alert |
| 02/14/2020 | ALKS | Buy Now | Alkermes | $31.72 | -33.8% | Cory Kasimov69% | $25 → $21 | Downgrade | Overweight → Neutral | Get Alert |
| 11/04/2019 | BNTX | Buy Now | BioNTech | $105.42 | -78.18% | Cory Kasimov69% | → $23 | Initiates | → Overweight | Get Alert |
| 10/23/2019 | BIIB | Buy Now | Biogen | $122.42 | 112.38% | Cory Kasimov69% | $244 → $260 | Maintains | Neutral | Get Alert |
| 08/29/2019 | AMGN | Buy Now | Amgen | $279.90 | -29.26% | Cory Kasimov69% | $191 → $198 | Maintains | Neutral | Get Alert |
| 07/31/2019 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Cory Kasimov69% | — | Initiates | → Overweight | Get Alert |
| 01/02/2019 | MRNA | Buy Now | Moderna | $27.51 | -20.03% | Cory Kasimov69% | → $22 | Initiates | → Overweight | Get Alert |
| 11/14/2018 | JNCE | Buy Now | Jounce Therapeutics | — | — | Cory Kasimov69% | — | Downgrade | Neutral → Underweight | Get Alert |
| 11/02/2018 | PBYI | Buy Now | Puma Biotechnology | $3.23 | 612.07% | Cory Kasimov69% | $83 → $23 | Maintains | Underweight | Get Alert |
| 11/02/2018 | PBYI | Buy Now | Puma Biotechnology | $3.23 | 612.07% | Cory Kasimov69% | $83 → $23 | Downgrade | Overweight → Underweight | Get Alert |
| 10/31/2018 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | $71 → $16 | Downgrade | Overweight → Neutral | Get Alert |
| 10/24/2018 | BIIB | Buy Now | Biogen | $122.42 | 256.15% | Cory Kasimov69% | $445 → $436 | Maintains | Overweight | Get Alert |
| 08/10/2018 | JNCE | Buy Now | Jounce Therapeutics | — | — | Cory Kasimov69% | $12 → $10 | Maintains | Neutral | Get Alert |
| 08/10/2018 | PBYI | Buy Now | Puma Biotechnology | $3.23 | 2469.66% | Cory Kasimov69% | $80 → $83 | Maintains | Overweight | Get Alert |
| 07/27/2018 | AMGN | Buy Now | Amgen | $279.90 | -31.4% | Cory Kasimov69% | $191 → $192 | Maintains | Neutral | Get Alert |
| 06/04/2018 | JNCE | Buy Now | Jounce Therapeutics | — | — | Cory Kasimov69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/31/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 113.93% | Cory Kasimov69% | $127 → $133 | Maintains | Overweight | Get Alert |
| 05/01/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov69% | $60 → $63 | Maintains | Neutral | Get Alert |
| 04/24/2018 | INCY | Buy Now | Incyte | $62.48 | 40.86% | Cory Kasimov69% | $96 → $88 | Maintains | Overweight | Get Alert |
| 04/09/2018 | INCY | Buy Now | Incyte | $62.48 | 53.66% | Cory Kasimov69% | $149 → $96 | Maintains | Overweight | Get Alert |
| 03/21/2018 | CELG | Buy Now | Celgene | — | — | Cory Kasimov69% | → $110 | Reinstates | → Overweight | Get Alert |
| 02/21/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.37 | 67.64% | Cory Kasimov69% | $68 → $66 | Maintains | Overweight | Get Alert |
| 02/14/2018 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov69% | — | Downgrade | Neutral → Underweight | Get Alert |
| 02/14/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/14/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov69% | $62 → $60 | Maintains | Neutral | Get Alert |
| 02/14/2018 | LXRX | Buy Now | Lexicon Pharmaceuticals | $0.73 | 1270.99% | Cory Kasimov69% | $15 → $10 | Maintains | Underweight | Get Alert |
| 02/14/2018 | DVAX | Buy Now | Dynavax Technologies | $11.38 | 119.78% | Cory Kasimov69% | $310 → $250 | Maintains | Neutral | Get Alert |
| 01/24/2018 | AMGN | Buy Now | Amgen | $279.90 | -32.48% | Cory Kasimov69% | $184 → $189 | Maintains | Neutral | Get Alert |
| 01/24/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $607.48 | -24.77% | Cory Kasimov69% | $455 → $457 | Maintains | Neutral | Get Alert |
| 01/24/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 107.5% | Cory Kasimov69% | $131 → $129 | Maintains | Outperform | Get Alert |
| 01/24/2018 | PBYI | Buy Now | Puma Biotechnology | $3.23 | 2717.34% | Cory Kasimov69% | $138 → $91 | Maintains | Overweight | Get Alert |
| 06/19/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | — | Upgrade | Sell → Neutral | Get Alert |
| 05/17/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | — | Upgrade | Neutral → Overweight | Get Alert |
| 02/21/2017 | JNCE | Buy Now | Jounce Therapeutics | — | — | Cory Kasimov69% | → $28 | Initiates | → Overweight | Get Alert |
| 02/03/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | → $36 | Downgrade | Neutral → Sell | Get Alert |
| 12/20/2016 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | → $36 | Upgrade | Sell → Neutral | Get Alert |
| 12/14/2016 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/25/2016 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | — | Initiates | → Sell | Get Alert |
| 10/21/2016 | ALKS | Buy Now | Alkermes | $31.72 | — | Cory Kasimov69% | — | Upgrade | Neutral → Overweight | Get Alert |
| 08/11/2016 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov69% | $210 → $140 | Maintains | Overweight | Get Alert |
| 08/05/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 104.28% | Cory Kasimov69% | $120 → $127 | Maintains | Overweight | Get Alert |
| 04/13/2016 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | $42 → $15 | Downgrade | Overweight → Neutral | Get Alert |
| 03/29/2016 | PBYI | Buy Now | Puma Biotechnology | $3.23 | 2655.42% | Cory Kasimov69% | $105 → $89 | Maintains | Overweight | Get Alert |
| 02/29/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.37 | 115.9% | Cory Kasimov69% | $125 → $85 | Maintains | Market Outperform | Get Alert |
| 02/10/2016 | REGN | Buy Now | Regeneron Pharmaceuticals | $607.48 | -21.48% | Cory Kasimov69% | $537 → $477 | Maintains | Neutral | Get Alert |
| 01/28/2016 | INCY | Buy Now | Incyte | $62.48 | 84.07% | Cory Kasimov69% | $125 → $115 | Maintains | Overweight | Get Alert |
| 10/01/2015 | CELG | Buy Now | Celgene | — | — | Cory Kasimov69% | → $152 | Upgrade | Neutral → Overweight | Get Alert |
| 08/27/2015 | PBYI | Buy Now | Puma Biotechnology | $3.23 | 3677.09% | Cory Kasimov69% | → $122 | Initiates | → Overweight | Get Alert |
| 08/07/2015 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | $92 → $103 | Maintains | Overweight | Get Alert |
| 06/18/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 142.88% | Cory Kasimov69% | $140 → $151 | Maintains | Overweight | Get Alert |
| 06/15/2015 | BLUE | Buy Now | bluebird bio | $4.00 | 6000% | Cory Kasimov69% | $4000 → $4880 | Maintains | Overweight | Get Alert |
| 06/01/2015 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov69% | — | Initiates | → Overweight | Get Alert |
| 05/27/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 125.19% | Cory Kasimov69% | $125 → $140 | Maintains | Overweight | Get Alert |
| 03/19/2015 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov69% | $74 → $82 | Maintains | Overweight | Get Alert |
| 02/26/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 93.02% | Cory Kasimov69% | $110 → $120 | Maintains | Overweight | Get Alert |
| 02/26/2015 | BLUE | Buy Now | bluebird bio | $4.00 | 2825% | Cory Kasimov69% | $2060 → $2340 | Maintains | Overweight | Get Alert |
| 02/24/2015 | ONCE | Buy Now | Spark Therapeutics | — | — | Cory Kasimov69% | → $74 | Initiates | → Overweight | Get Alert |
| 02/10/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 76.93% | Cory Kasimov69% | $101 → $110 | Maintains | Overweight | Get Alert |
| 12/11/2014 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | 62.46% | Cory Kasimov69% | $90 → $101 | Maintains | Overweight | Get Alert |
| 12/05/2014 | GILD | Buy Now | Gilead Sciences | $103.67 | 16.72% | Cory Kasimov69% | $110 → $121 | Maintains | Overweight | Get Alert |
| 08/08/2014 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | $101 → $92 | Maintains | Overweight | Get Alert |
| 07/25/2014 | CELG | Buy Now | Celgene | — | — | Cory Kasimov69% | $85 → $95 | Maintains | Neutral | Get Alert |
| 07/24/2014 | GILD | Buy Now | Gilead Sciences | $103.67 | 6.11% | Cory Kasimov69% | $100 → $110 | Maintains | Overweight | Get Alert |
| 06/18/2014 | BLUE | Buy Now | bluebird bio | $4.00 | 1225% | Cory Kasimov69% | $880 → $1060 | Maintains | Overweight | Get Alert |
| 05/29/2014 | BIIB | Buy Now | Biogen | $122.42 | 206.32% | Cory Kasimov69% | $300 → $375 | Upgrade | Neutral → Overweight | Get Alert |
| 05/29/2014 | CELG | Buy Now | Celgene | — | — | Cory Kasimov69% | $90 → $85 | Downgrade | Overweight → Neutral | Get Alert |
| 02/25/2014 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.37 | 67.64% | Cory Kasimov69% | → $66 | Initiates | → Overweight | Get Alert |
| 12/18/2013 | GILD | Buy Now | Gilead Sciences | $103.67 | -3.54% | Cory Kasimov69% | $85 → $100 | Maintains | Overweight | Get Alert |
| 07/15/2013 | BLUE | Buy Now | bluebird bio | $4.00 | 1000% | Cory Kasimov69% | → $880 | Initiates | → Overweight | Get Alert |
| 05/07/2013 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | $33 → $45 | Maintains | Overweight | Get Alert |
| 03/11/2013 | CLVS | Buy Now | Clovis Oncology | — | — | Cory Kasimov69% | $18 → $33 | Maintains | Overweight | Get Alert |
| 11/01/2012 | ALKS | Buy Now | Alkermes | $31.72 | -18.03% | Cory Kasimov69% | $25 → $26 | Maintains | Overweight | Get Alert |
| 09/27/2012 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.17 | -19.58% | Cory Kasimov69% | $47 → $50 | Maintains | Overweight | Get Alert |
| 09/17/2012 | GILD | Buy Now | Gilead Sciences | $103.67 | -27.65% | Cory Kasimov69% | $35 → $37.5 | Maintains | Overweight | Get Alert |
| 07/11/2012 | LIFE | Buy Now | aTyr Pharma | — | — | Cory Kasimov69% | $728 → $644 | Downgrade | Overweight → Neutral | Get Alert |
| 05/31/2012 | ALKS | Buy Now | Alkermes | $31.72 | -27.49% | Cory Kasimov69% | $24 → $23 | Maintains | Overweight | Get Alert |
| 04/26/2012 | INCY | Buy Now | Incyte Genomics | $62.48 | -59.98% | Cory Kasimov69% | $23 → $25 | Maintains | Overweight | Get Alert |
